Ingevity stock has surged 41% in six months, with strong growth potential and positive earnings

From Nasdaq: 2025-03-10 06:36:00

Ingevity Corporation’s NGVT stock has surged 41% in the past six months. Analysts are optimistic about NGVT’s growth potential, with earnings estimates for 2025 up by 29%. The company has a history of beating earnings estimates, with an average surprise of 202.9%.

Ingevity’s return on equity (ROE) is at 41.4%, significantly higher than the industry average of 15.5%. The company is strategically repositioning its Performance Chemicals segment to drive growth and improve margins. Recent acquisitions, like Capa and Ozark Materials, are expected to boost revenue and earnings.

With a Zacks Rank #1 (Strong Buy), NGVT is a top pick in the Basic Materials space. Other top-ranked stocks include AXTA, CRS, and ORLA. Analysts project positive earnings growth for these companies, making them attractive investment options for growth-oriented investors.

Zacks experts have identified 5 stocks, including NGVT, with the potential to double in value in 2024. These under-the-radar stocks offer a unique opportunity for investors to capitalize on significant growth. Analysts recommend keeping an eye on these stocks for potential high returns in the coming year.



Read more at Nasdaq: Here’s What Makes Ingevity Stock a Solid Choice Right Now